Ikarian Capital »

Inhibrx Biosciences shares owned by Ikarian Capital

Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $660k 42k 15.66
2024-06-30 $3.3M 230k 14.17

More positions owned by Ikarian Capital

Vertex Pharmaceuticals Incorporated Put Option (VRTX)
Amgen Call Option (AMGN)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Tarsus Pharmaceuticals (TARS)
Beigene Sponsored Adr Call Option (BGNE)
Anaptysbio Inc Common Put Option (ANAB)
Crinetics Pharmaceuticals In (CRNX)
Celldex Therapeutics Com New Put Option (CLDX)
Soleno Therapeutics Call Option (SLNO)
Janux Therapeutics Put Option (JANX)
Biohaven Put Option (BHVN)
Miragen Therapeutics Call Option (VRDN)
Immunovant Call Option (IMVT)
Capricor Therapeutics Com New Put Option (CAPR)
Arcus Biosciences Incorporated Call Option (RCUS)

View all positions for Ikarian Capital

Top funds holding Inhibrx Biosciences

Viking Global Investors
Perceptive Advisors
BlackRock
BlackRock
Sofinnova Ventures
Vanguard Group
Slotnik Capital
Geode Capital Management
Morgan Stanley
Caption Management
Kennedy Capital Management
Arrowpoint Asset Management
Susquehanna International
State Street Corporation
Schonfeld Strategic Advisors

View all funds holding Inhibrx Biosciences